214 related articles for article (PubMed ID: 11875594)
1. Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US?
Hanbidge AE
Can J Gastroenterol; 2002 Feb; 16(2):101-5. PubMed ID: 11875594
[TBL] [Abstract][Full Text] [Related]
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.
Delbeke D; Pinson CW
J Hepatobiliary Pancreat Surg; 2004; 11(1):4-10. PubMed ID: 15747028
[TBL] [Abstract][Full Text] [Related]
4. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
5. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
Mertz HR; Sechopoulos P; Delbeke D; Leach SD
Gastrointest Endosc; 2000 Sep; 52(3):367-71. PubMed ID: 10968852
[TBL] [Abstract][Full Text] [Related]
6. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.
Matsumoto I; Shirakawa S; Shinzeki M; Asari S; Goto T; Ajiki T; Fukumoto T; Kitajima K; Ku Y
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):712-8. PubMed ID: 23353642
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and staging of pancreatic cancer by positron emission tomography.
Berberat P; Friess H; Kashiwagi M; Beger HG; Büchler MW
World J Surg; 1999 Sep; 23(9):882-7. PubMed ID: 10449814
[TBL] [Abstract][Full Text] [Related]
8. Advances in imaging for pancreatic disease.
Del Frate C; Zanardi R; Mortele K; Ros PR
Curr Gastroenterol Rep; 2002 Apr; 4(2):140-8. PubMed ID: 11900679
[TBL] [Abstract][Full Text] [Related]
9. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
10. Radiology of pancreatic adenocarcinoma: current status of imaging.
Sahani DV; Shah ZK; Catalano OA; Boland GW; Brugge WR
J Gastroenterol Hepatol; 2008 Jan; 23(1):23-33. PubMed ID: 18171340
[TBL] [Abstract][Full Text] [Related]
11. Staging of pancreatic adenocarcinoma by imaging studies.
Wong JC; Lu DS
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1301-8. PubMed ID: 18948228
[TBL] [Abstract][Full Text] [Related]
12. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.
Balci NC; Semelka RC
Eur J Radiol; 2001 May; 38(2):105-12. PubMed ID: 11335092
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based imaging of pancreatic malignancies.
Kinney T
Surg Clin North Am; 2010 Apr; 90(2):235-49. PubMed ID: 20362784
[TBL] [Abstract][Full Text] [Related]
14. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Farma JM; Santillan AA; Melis M; Walters J; Belinc D; Chen DT; Eikman EA; Malafa M
Ann Surg Oncol; 2008 Sep; 15(9):2465-71. PubMed ID: 18551347
[TBL] [Abstract][Full Text] [Related]
15. [Ductal adenocarcinoma and unusual differential diagnosis].
Haage P; Schwartz CA; Scharwächter C
Radiologe; 2016 Apr; 56(4):325-37. PubMed ID: 27000276
[TBL] [Abstract][Full Text] [Related]
16. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.
Raman SP; Chen Y; Fishman EK
Semin Oncol; 2015 Feb; 42(1):40-58. PubMed ID: 25726051
[TBL] [Abstract][Full Text] [Related]
19. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic carcinoma: imaging update 2001.
Freeny PC
Dig Dis; 2001; 19(1):37-46. PubMed ID: 11385250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]